Tema ETFs’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.65M Sell
10,986
-2,786
-20% -$303K 0.05% 210
2026
Q1
$1.27M Buy
13,772
+5,857
+74% +$588K 0.09% 202
2025
Q4
$808K Sell
7,915
-2,370
-23% -$212K 0.06% 273
2025
Q3
$643K Sell
10,285
-1,065
-9% -$57.9K 0.05% 338
2025
Q2
$591K Buy
11,350
+1,190
+12% +$53.1K 0.16% 129
2025
Q1
$433K Sell
10,160
-25,960
-72% -$1.12M 0.13% 118
2024
Q4
$1.1M Buy
+36,120
New +$1.02M 0.46% 62

Other funds holding GH

Tema ETFs's GH Position: Q2 2026 in Review

Tema ETFs reduced its Guardant Health (GH) stake by 20% in Q2 2026, selling an estimated $303K and leaving 10,986 shares worth $1.65M. The position accounts for 0.05% of the portfolio, ranked #210.

Tema ETFs first reported a position in GH in Q4 2024 and has held it in 7 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Tema ETFs held 10,986 shares of Guardant Health worth $1.65M as of Q2 2026.
  • Tema ETFs sold 2,786 Guardant Health shares in Q2 2026, an estimated $303K.
  • Guardant Health made up 0.05% of Tema ETFs's portfolio in Q2 2026, its #210 holding.
  • Tema ETFs first reported a position in Guardant Health in Q4 2024 and has held it in 7 quarters since.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Tema ETFs's 13F filing for Q2 2026, filed 10 Jul 2026.